PULSE4PULSE
Newsome Park Strategies, in collaboration with esteemed client and tech partner PULSE4PULSE, proudly introduces a cutting-edge screening tool poised to revolutionize modern medicine. Committed to advancing health, we aim to establish this innovative technology as the gold standard for monitoring heart, cardiovascular, and autonomic nervous system health—a comprehensive report card for your heart.
This groundbreaking screening tool, offering more information on baseline heart health than ever available before without specialist referral, places a powerful tool in the hands of our Primary Care front-line providers. Covering over 50,000 miles of vasculature and providing over 150 data points, it paints an easy-to-discuss picture of patients baseline heart health, fostering awareness, dialogue, and an elevated standard of care.
Not only does it enable early detection of heart-related diseases and identify predispositions in asymptomatic patients, but it also presents the most effective preventive measure in modern medicine. This innovative solution addresses health disparities, particularly in minority and rural communities, with the potential to save lives and enhance outcomes globally.
Endorsed by prestigious health systems, this screening tool has the power to create a seismic shift in Primary Care and Heart Health. It represents a substantial leap forward in preventative heart health, making a difference globally. When this product becomes more widely available, lives are saved, and health outcomes are elevated—it’s not just a product; it’s a game-changing solution!
CEO
FDA Approved
- Non-Invasive
- 15 minute (In-Office)
- Autonomic, Vascular and Cardiovascular Risk Assessment
- Groundbreaking Preventative Screening technology.
Earlier Detection for Better Outcomes
THE PROBLEM
- Heart Disease is the main cause of DEATH in the world.
- 55.4 Million people in 2020 alone died from cardiovascular disease (CVD), with ischemic heart disease and stroke accounting for 17.9 million.......that 31% of those deaths
- 3 of 4 Patients who develop Peripheral Artery Disease (PAD) DO NOT SHOW SYMPTOMS
- Patients at highest risk for CVD are those with a history of Chronic Kidney Disease, Hypertension, Diabetes, excessive Alcohol use.
- Modifiable risk factors account for more than 70% of ALL CVD. This means that CVD can be reduced by disease prevention and early diagnosis.
PULSE4PULSE Diagnostic Testing
Our Mission
To empower Primary Care providers to Proactively Identify Cardiovascular and Peripheral Artery Disease indicators EARLIER, in even their asymptomatic patients. Earlier detection is made possible by our cutting-edge technology that focuses on the microvasculature, where diseases start.
NEW TOOL FOR DIAGNOSING HIDDEN ILLNESS
- Onsite diagnostic test
- 15 minute non-invasive
- Tests the cardiovascular and autonomic nervous system
- Administered by P4P medical technician
- 60% of patients qualify
NEW TOOL FOR DIAGNOSING HIDDEN ILLNESS
SUDOMOTOR TEST
- The device stimulates the patient's sweat glands by emitting a low voltage current through a glass plate.
- Results for this test helps the physician determine if the patient is going to be at risk of vascular disease or neuropathy.
AUTONOMIC NERVOUS SYSTEM TEST
- We report the heart- rate variability with beat-to-beat blood pressure in the patient after deep-breathing, head-tilt and Valsalva maneuver tests and compare to base-line.
- Many diseases of the nervous system identified.
ANKLE-BRACHIAL INDEX TEST
- A measurement of the ratio of blood pressure of the upper and lower body.
- Results indicate if the patient is suffering from vascular disease.
- Ability to test the vascular system at the micro-level.
HOW PULSE4PULSE WORKS
Patient comes into the practice for their regular appointment
Patient Completes Intake Form
Our medical technician conducts test
Results are immediately available for the Provider’s review
Patient follow-up visit scheduled
Practice receives all claims/remittances
P4P invoices per test
WHO QUALIFIES FOR SCREENING
Quick and easy reimbursement prequalification process. If the patient answers yes to any of these questions, they are cleared to receive the assessment. Results are compatible with all Electronic Medical Records systems and are made available to the practitioner in real time.
Why So Easy?
Payers realize and acknowledge that a preemptive screening, such as PULSE4PULSE, truly represents actuating Value-Based Medicine, reduces referrals to specialist and labs, promotes early detection and better outcomes. They also understand the cost savings associated with the aforementioned benefits.
REAL-TIME RESULTS AND RECOMMENDATIONS
- Turnkey wellness assessment service with $0 cost to practice.
- Instant, easy-to-interpret results with summary page extrapolated from the 3 simultaneous tests per the PULSE4PULSE algorithm.
- Identifies chronic diseases early to reduce invasive and costly interventions
BILLING OPTIONS
ACCEPTED BY MEDICARE, MEDICAID AND MOST MAJOR PRIVATE INSURANCE CARRIERS
Option 1
- Billing provided by PULSE4PULSE team on our national platform
- Established success working with insurance companies minimizing denials
Option 2
- Billing facilitated by the client through the individual practice with existing system
- PULSE4PULSE provides a billing liaison
BILLING DIAGNOSTIC CODES
There are 5 billing diagnostic codes approved by Medicare, Medicaid and most private payers up to 3 times per year
- Ankle Brachial Test (93923)
- Autonomic Function Test (95921)
- Sudomotor Test (95923)
- Electrocardiogram (93040)
- Pulse Oximetry (94761)
Additional Billing Code
- Follow-up Office Visit (99214)
Finances and Revenue-Fee for Service
- $0 start up cost
- $0 ongoing financial investment
- National average annual revenue increase of $150,000 net with one MD @ 5 patient screenings per day
- When a follow-up visit is included, the revenue increases to $160 -$170 per physician, per each patient screening
- *table includes follow up visit
